Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 16:15 | 3/8/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Tasse Daniel | I0 | DO | CEO | 1 | P | 14 | 0.8300 | 0 | 17 | 17 | D | |||||||||||||||
2/8/24 17:02 | 2/6/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Ndu Adora | I0 | D | 1 | P | 2 | 0.8899 | 0 | 2 | 2 | D | ||||||||||||||||
8/28/23 16:35 | 8/25/23 | DBVT | Health | BioPrd | Biological Products, (No Diag | Morris Timothy E | I0 | D | 1 | P | 18 | 1.52 | 0 | 12 | 12 | D | ||||||||||||||||
8/3/23 16:40 | 8/1/23 | DBVT | Health | BioPrd | Biological Products, (No Diag | Soland Daniel B | I0 | D | 1 | P | 24 | 1.62 | 0 | 15 | 300 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |